title: Limitation of inverse probability-of-censoring weights in estimating survival in the presence of strong selection bias.
abstract: In time-to-event analyses, artificial censoring with correction for induced selection bias using inverse probability-of-censoring weights can be used to 1) examine the natural history of a disease after effective interventions are widely available, 2) correct bias due to noncompliance with fixed or dynamic treatment regimens, and 3) estimate survival in the presence of competing risks. Artificial censoring entails censoring participants when they meet a predefined study criterion, such as exposure to an intervention, failure to comply, or the occurrence of a competing outcome. Inverse probability-of-censoring weights use measured common predictors of the artificial censoring mechanism and the outcome of interest to determine what the survival experience of the artificially censored participants would be had they never been exposed to the intervention, complied with their treatment regimen, or not developed the competing outcome. Even if all common predictors are appropriately measured and taken into account, in the context of small sample size and strong selection bias, inverse probability-of-censoring weights could fail because of violations in assumptions necessary to correct selection bias. The authors used an example from the Multicenter AIDS Cohort Study, 1984-2008, regarding estimation of long-term acquired immunodeficiency syndrome-free survival to demonstrate the impact of violations in necessary assumptions. Approaches to improve correction methods are discussed.
authors.affiliation: Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, 27599-7435, USA. cjhowe@email.unc.edu
authors.forename: Chanelle J
authors.initials: CJ
authors.lastname: Howe
authors.forename: Stephen R
authors.initials: SR
authors.lastname: Cole
authors.forename: Joan S
authors.initials: JS
authors.lastname: Chmiel
authors.forename: Alvaro
authors.initials: A
authors.lastname: Muñoz
mesh_terms: D023241:Antiretroviral Therapy, Highly Active / Q000401:mortality; D018572:Disease-Free Survival; D006678:HIV / Q000302:isolation & purification; D015658:HIV Infections / Q000188:drug therapy / Q000453:epidemiology / Q000401:mortality*; D006801:Humans; D008432:Mathematical Computing; D015233:Models, Statistical; D015337:Multicenter Studies as Topic; D010349:Patient Compliance; D012107:Research Design; D015983:Selection Bias; D016019:Survival Analysis; D014481:United States / Q000453:epidemiology